scholarly journals Maribavir Versus Valganciclovir for Pre-Emptive Treatment of Cytomegalovirus Viremia: A Randomized, Dose-Ranging, Phase 2 Study Among Hematopoietic Stem Cell Transplant and Solid Organ Transplant Recipients

2017 ◽  
Vol 23 (3) ◽  
pp. S191-S192 ◽  
Author(s):  
Johan A. Maertens ◽  
Catherine Cordonnier ◽  
Peter Jaksch ◽  
Xavier Poiré ◽  
Jingyang J. Wu ◽  
...  
Keyword(s):  
Hematopoietic Stem Cell Transplant ◽  
Stem Cell Transplant ◽  
Organ Transplant ◽  
Solid Organ ◽  
Cell Transplant ◽  
Transplant Recipients ◽  
Hematopoietic Stem ◽  
Phase 2 Study ◽  
Dose Ranging ◽  
Solid Organ Transplant Recipients

scholarly journals Towards a Prophylactic Vaccine for the Prevention of HCMV Infection

Vaccines ◽  
2021 ◽  
Vol 9 (9) ◽  
pp. 968
Author(s):  
Gaëtan Ligat ◽  
Sophie Alain ◽  
Sébastien Hantz
Keyword(s):  
Hematopoietic Stem Cell Transplant ◽  
Hcmv Infection ◽  
Stem Cell Transplant ◽  
Severe Disease ◽  
Organ Transplant ◽  
Human Herpesvirus ◽  
Solid Organ ◽  
Cell Transplant ◽  
Transplant Recipients ◽  
Hematopoietic Stem

Human cytomegalovirus (HCMV) or human herpesvirus 5, is a ubiquitous human herpesvirus, which can cause severe disease in immunocompromised patients (AIDS patients and solid organ transplant or hematopoietic stem cell transplant recipients) [...]

Sign in / Sign up

Export Citation Format

Share Document